ANTI-VIRAL COMPOUNDS

Compounds effective in inhibiting replication of Hepatitis C virus ("HCV") or other viruses are disclosed. This invention is also directed to compositions comprising such compounds, co-formulation or co-administration of such compounds with other anti-viral or therapeutic agents, processes...

Full description

Saved in:
Bibliographic Details
Main Authors MADIGAN, DAROLD, L, ROCKWAY, TODD, W, KRUEGER, ALLAN, C, KEMPF, DALE, J, TUFANO, MICHAEL, D, LIU, DACHUN, WAGNER, ROLF, SHANLEY, JASON, P, MARING, CLARENCE, J, DONNER, PAMELA, L, MOTTER, CHRISTOPHER, E, DEGOEY, DAVID, A, COOPER, CURT, S, PRATT, JOHN, K, MCDANIEL, KEITH,F, ZHANG, RONG, IWASAKI, NOBUHIKO, GREEN, BRIAN, E, ANDERSON, DAVID, D, BETEBENNER, DAVID, A
Format Patent
LanguageEnglish
French
German
Published 18.01.2012
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:Compounds effective in inhibiting replication of Hepatitis C virus ("HCV") or other viruses are disclosed. This invention is also directed to compositions comprising such compounds, co-formulation or co-administration of such compounds with other anti-viral or therapeutic agents, processes and intermediates for the syntheses of such compounds, and methods of using such compounds for the treatment of HCV or other viral infections.
Bibliography:Application Number: EP20060848055